# TEVIMBRA
> **BLA761417** · Biologics License Application · Sponsor: BEIGENE · Approved 2024-12-26
## Drug
- **FDA Application Number:** BLA761417
- **Application type:** Biologics License Application
- **Brand name:** TEVIMBRA
- **Generic name:** Tislelizumab-Jsgr
- **Active ingredients:** TISLELIZUMAB-JSGR
- **Dosage form:** INJECTABLE
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** BEIGENE
- **First approval:** 2024-12-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761417)
---
*MORVS · CC0 1.0*